Average Co-Inventor Count = 5.29
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Seattle Genetics, Inc. (13 from 132 patents)
2. Glaxosmithkline LLC (4 from 356 patents)
3. Seagen Inc. (3 from 64 patents)
4. Praecis Pharmaceuticals, Inc. (3 from 43 patents)
5. University of Minnesota (1 from 2,304 patents)
6. Agensys, Inc. (1 from 196 patents)
24 patents:
1. 11331394 - CD19 binding agents and uses thereof
2. 11319526 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
3. 11033561 - Methods of inhibition of protein fucosylation in vivo using fucose analogs
4. 10443035 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
5. 10350228 - Treatment of sickle cell disease and inflammatory conditions
6. 10342811 - Methods of inhibition of protein fucosylation in vivo using fucose analogs
7. 9919061 - CD19 binding agents and uses thereof
8. 9816069 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
9. 9725500 - Methods for screening antibodies
10. 9504702 - Methods of inhibition of protein fucosylation in vivo using fucose analogs
11. 9073993 - CD19 binding agents and uses thereof
12. 8993326 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
13. 8598089 - Methods for synthesis of encoded libraries
14. 8574907 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
15. 8410028 - Methods for synthesis of encoded libraries